These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Data-Driven Chronic Allograft Phenotypes: A Novel and Validated Complement for Histologic Assessment of Kidney Transplant Biopsies. Vaulet T; Divard G; Thaunat O; Koshy P; Lerut E; Senev A; Aubert O; Van Loon E; Callemeyn J; Emonds MP; Van Craenenbroeck A; De Vusser K; Sprangers B; Rabeyrin M; Dubois V; Kuypers D; De Vos M; Loupy A; De Moor B; Naesens M J Am Soc Nephrol; 2022 Nov; 33(11):2026-2039. PubMed ID: 36316096 [TBL] [Abstract][Full Text] [Related]
3. The Histological Picture of Indication Biopsies in the First 2 Weeks after Kidney Transplantation. Van Loon E; Lerut E; Senev A; Coemans M; Pirenne J; Monbaliu D; Jochmans I; Sainz Barriga M; De Vusser K; Van Craenenbroeck AH; Sprangers B; Emonds MP; Kuypers D; Naesens M Clin J Am Soc Nephrol; 2020 Oct; 15(10):1484-1493. PubMed ID: 32778537 [TBL] [Abstract][Full Text] [Related]
4. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection. Matignon M; Muthukumar T; Seshan SV; Suthanthiran M; Hartono C Transplantation; 2012 Sep; 94(6):603-11. PubMed ID: 22932115 [TBL] [Abstract][Full Text] [Related]
5. Pathologic characteristics of early or late acute cellular rejection and outcome after kidney transplant. Wu K; Budde K; Schmidt D; Neumayer HH; Rudolph B Exp Clin Transplant; 2014 Aug; 12(4):314-22. PubMed ID: 25095709 [TBL] [Abstract][Full Text] [Related]
6. Data-driven Derivation and Validation of Novel Phenotypes for Acute Kidney Transplant Rejection using Semi-supervised Clustering. Vaulet T; Divard G; Thaunat O; Lerut E; Senev A; Aubert O; Van Loon E; Callemeyn J; Emonds MP; Van Craenenbroeck A; De Vusser K; Sprangers B; Rabeyrin M; Dubois V; Kuypers D; De Vos M; Loupy A; De Moor B; Naesens M J Am Soc Nephrol; 2021 May; 32(5):1084-1096. PubMed ID: 33687976 [TBL] [Abstract][Full Text] [Related]
7. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection. Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493 [TBL] [Abstract][Full Text] [Related]
8. Impact of the Current Versus the Previous Diagnostic Threshold on the Outcome of Patients With Borderline Changes Suspicious for T Cell-mediated Rejection Diagnosed on Indication Biopsies. McRae M; Bouchard-Boivin F; Béland S; Noël R; Côté I; Lapointe I; Lesage J; Latulippe E; Riopel J; Santoriello D; Husain SA; Désy O; Houde I; Batal I; De Serres SA Transplantation; 2018 Dec; 102(12):2120-2125. PubMed ID: 29916985 [TBL] [Abstract][Full Text] [Related]
9. Designation of T-cell-mediated rejection type Ib and IIa reflects the type of rejection rather than the severity in the Banff classification. Wu K; Budde K; Schmidt D; Neumayer HH; Rudolph B Exp Clin Transplant; 2014 Oct; 12(5):415-23. PubMed ID: 25299369 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for death in kidney transplant patients: analysis from a large protocol biopsy registry. Abeling T; Scheffner I; Karch A; Broecker V; Koch A; Haller H; Schwarz A; Gwinner W Nephrol Dial Transplant; 2019 Jul; 34(7):1171-1181. PubMed ID: 29860340 [TBL] [Abstract][Full Text] [Related]